| 0 (0%) | 09-27 09:31 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |   |
|||
| Targets | 6-month : | 14.4  |
1-year : | 15.18 |
| Resists | First : | 12.33 |
Second : | 13 |
| Pivot price | 12.07 |
|||
| Supports | First : | 11.25 |
Second : | 9.36 |
| MAs | MA(5) : | 11.9 |
MA(20) : | 12.14 |
| MA(100) : | 12 |
MA(250) : | 15 |
|
| MACD | MACD : | 0 |
Signal : | 0.1 |
| %K %D | K(14,3) : | 25 |
D(3) : | 23 |
| RSI | RSI(14): 47.5 |
|||
| 52-week | High : | 24.22 | Low : | 9.3 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ AVNS ] has closed above bottom band by 18.7%. Bollinger Bands are 24.5% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 11.79 - 11.85 | 11.85 - 11.9 |
| Low: | 11.39 - 11.46 | 11.46 - 11.52 |
| Close: | 11.67 - 11.77 | 11.77 - 11.86 |
Thu, 25 Sep 2025
Counterpoint Mutual Funds LLC Invests $288,000 in Avanos Medical, Inc. $AVNS - MarketBeat
Tue, 23 Sep 2025
Strs Ohio Takes Position in AVANOS MEDICAL, INC. $AVNS - MarketBeat
Thu, 18 Sep 2025
Avanos Medical Buys Nexus Medical to Bolster Critical Care Portfolio - Zacks Investment Research
Mon, 15 Sep 2025
Avanos Medical Acquires Nexus Medical to Strengthen Nutrition and Medication Delivery in Critical Care - PR Newswire
Mon, 15 Sep 2025
Critical Care Innovation: Avanos Medical Acquires Nexus Medical's Advanced NICU Technology Platform - Stock Titan
Fri, 29 Aug 2025
The Bottom Fishing Club - Avanos Medical: Bargain Defensive Choice (NYSE:AVNS) - Seeking Alpha
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 46 (M) |
| Shares Float | 45 (M) |
| Held by Insiders | 4 (%) |
| Held by Institutions | 98.4 (%) |
| Shares Short | 2,730 (K) |
| Shares Short P.Month | 1,900 (K) |
| EPS | -10.03 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 16.76 |
| Profit Margin | -66.9 % |
| Operating Margin | 1.4 % |
| Return on Assets (ttm) | 2.1 % |
| Return on Equity (ttm) | -46.2 % |
| Qtrly Rev. Growth | 1.8 % |
| Gross Profit (p.s.) | 8.03 |
| Sales Per Share | 14.92 |
| EBITDA (p.s.) | 1.9 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 113 (M) |
| Levered Free Cash Flow | 101 (M) |
| PE Ratio | -1.18 |
| PEG Ratio | 0 |
| Price to Book value | 0.7 |
| Price to Sales | 0.78 |
| Price to Cash Flow | 4.81 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|